Aegon Asset Management believes that the prospects for the Japanese pharmaceuticals sector are set t...
Aegon Asset Management believes that the prospects for the Japanese pharmaceuticals sector are set to worsen after posting returns of 38.34% in sterling terms for the 12 months ending 2 January 2001. Matt Harris, Japan fund manager at the group, is concerned about a lack of new drugs coming to market over the next few years and also impending government healthcare reforms. Harris says: "There are fewer new drugs set to come to the market over the next few years compared with the last couple of years which could lead to a sales slowdown. "The Japanese government is also looking at a he...
To continue reading this article...
Join Professional Adviser for free
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes